Search research articles
Contact Us
Filters
Showing results (21-30 of 656) with videos related to
Page
of 66
Sort By:
The British Journal of Psychiatry. Supplement
|
May 1, 1992
The importance of serotonin-dopamine interactions in the action of clozapine
H Y Meltzer
Biological Psychiatry
|
February 22, 2000
Genetics and etiology of schizophrenia and bipolar disorder
H Y Meltzer
Psychopharmacology
|
August 3, 2000
Massive serum creatine kinase increases with atypical antipsychotic drugs: what is the mechanism and the message?
H Y Meltzer
Biochemical Pharmacology
|
February 1, 1975
Lack of effect of ouabain on creatine phosphokinase efflux from skeletal muscle
H Y Meltzer
Schizophrenia Bulletin
|
January 1, 1976
Neuromuscular dysfunction in schizophrenia
H Y Meltzer
The Psychiatric Clinics of North America
|
June 1, 1993
New drugs for the treatment of schizophrenia
H Y Meltzer
Journal of Clinical Psychopharmacology
|
February 1, 1995
The role of serotonin in schizophrenia and the place of serotonin-dopamine antagonist antipsychotics
H Y Meltzer
Research Communications in Chemical Pathology and Pharmacology
|
March 1, 1972
Muscle toxicity produced by phencyclidine and restraint stress
H Y Meltzer
Archives of General Psychiatry
|
December 1, 1994
Serotonin2A receptors in schizophrenia: relation to suicide
H Y Meltzer
Psychopharmacologia
|
October 14, 1975
Plasma creatine phosphokinase levels in rats following lysergic acid diethylamide
H Y Meltzer
Page
of 66
Search research articles
Search
Showing results (21-30 of 656) with videos related to
Sort By:
Page
of 66
The British Journal of Psychiatry. Supplement
|
May 1, 1992
The importance of serotonin-dopamine interactions in the action of clozapine
H Y Meltzer
Biological Psychiatry
|
February 22, 2000
Genetics and etiology of schizophrenia and bipolar disorder
H Y Meltzer
Psychopharmacology
|
August 3, 2000
Massive serum creatine kinase increases with atypical antipsychotic drugs: what is the mechanism and the message?
H Y Meltzer
Biochemical Pharmacology
|
February 1, 1975
Lack of effect of ouabain on creatine phosphokinase efflux from skeletal muscle
H Y Meltzer
Schizophrenia Bulletin
|
January 1, 1976
Neuromuscular dysfunction in schizophrenia
H Y Meltzer
The Psychiatric Clinics of North America
|
June 1, 1993
New drugs for the treatment of schizophrenia
H Y Meltzer
Journal of Clinical Psychopharmacology
|
February 1, 1995
The role of serotonin in schizophrenia and the place of serotonin-dopamine antagonist antipsychotics
H Y Meltzer
Research Communications in Chemical Pathology and Pharmacology
|
March 1, 1972
Muscle toxicity produced by phencyclidine and restraint stress
H Y Meltzer
Archives of General Psychiatry
|
December 1, 1994
Serotonin2A receptors in schizophrenia: relation to suicide
H Y Meltzer
Psychopharmacologia
|
October 14, 1975
Plasma creatine phosphokinase levels in rats following lysergic acid diethylamide
H Y Meltzer
Page
of 66